Viewing nowCombinationTrevel Tablets 80/5/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201802587 · Approved 2018.06.20 · Insurance code 693902870
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk
This drug is used for patients with essential hypertension whose blood pressure is not adequately controlled, and those at risk of cardiovascular diseases who require Rosuvastatin. The combination of Telmisartan and Amlodipine effectively controls blood pressure, thereby reducing the burden on the cardiovascular system. Rosuvastatin lowers cholesterol levels in patients with familial hypercholesterolemia or mixed hyperlipidemia and delays the progression of atherosclerosis. Additionally, it reduces the risk of cardiovascular diseases and aids in the prevention of complications after stroke, myocardial infarction, and vascular revascularization procedures. Therefore, this drug is used to simultaneously improve the management of blood pressure and blood lipids.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking a telmisartan/amlodipine combination and rosuvastatin as separate products, switching to this medicine (a combination product containing the same amounts of each active ingredient) may be considered for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased up to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when rosuvastatin 20 mg is administered to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased by approximately 2.4-fold and AUC by approximately 1.3-fold. Therefore, when administering this medicine, the potential risk associated with the increase in rosuvastatin Cmax should be assessed, and patients should be monitored closely.
This drug should not be administered to pregnant women. It can cause serious harm to the fetus, especially during the second and third trimesters, so if pregnancy is confirmed, use should be discontinued immediately. Patients allergic to any of the ingredients in this drug or those with certain hereditary diseases should not use it. Additionally, patients with severely impaired liver or kidney function, severe heart valve disease, or in shock should not take this medication. Elderly patients with hypertension or dyslipidemia, as well as patients with mild kidney or liver function impairment, or very low blood pressure, should be monitored more carefully when administering this medication. If symptoms such as myalgia, muscle weakness, or muscle cramps appear during use, consult a doctor immediately. These symptoms are rare but may progress to serious muscle disease. This drug may affect liver function, so regular liver function tests should be conducted before and during use. If liver enzyme levels rise significantly, it may be necessary to discontinue the medication. Patients with weak kidney function or at risk of hyperkalemia should frequently check their kidney function and potassium levels through blood tests. When taken with other medications, drug interactions may occur, so caution is needed, especially when combined with antihypertensives, diuretics, immunosuppressants, and statins. This drug should not be administered to breastfeeding women, and breastfeeding should be suspended during use. It is not recommended for children and adolescents under 18 years of age, as safety and efficacy have not been sufficiently established. In case of overdose, symptoms such as hypotension, arrhythmia, dizziness, and kidney dysfunction may occur, necessitating an immediate visit to a medical institution for appropriate emergency treatment. This drug should be kept out of reach of children and should not be transferred to another container.
Viral upper respiratory tract infection, dyspnea, anal bleeding, indigestion, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, oropharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, headache, dizziness, orthostatic hypotension, back pain, edema, flushing, palpitations, fatigue, nausea, myalgia, myopathy, rhabdomyolysis, weakness, angioedema, allergy, fever, leg pain, lethargy, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, vertigo, paresthesia, involuntary muscle contractions, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, irritability, infection, fungal infection, abscess, otitis media, asthma, bronchitis, epistaxis, dermatitis, rash, eczema, pruritus, frequent urination, cystitis, cerebrovascular disease, visual disturbances, conjunctivitis, ear pain, angioedema, erythema multiforme, rash, erythematous rash, papular rash, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, memory loss, peripheral neuropathy, cough, thrombocytopenia, liver dysfunction, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, hematuria, erectile dysfunction, gynecomastia, sexual dysfunction, insomnia, irritability, abnormal dreams, depersonalization, vasculitis, peripheral neuropathy, tremor, dysphagia, pancreatitis, gingival hyperplasia, burning sensation, rigidity, weight gain, weight loss, vasculitis, skin depigmentation, dry skin, hair loss, muscle weakness, single contraction, ataxia, hypertonicity, moist skin, apathy, anxiety, memory loss, gastritis, increased appetite, loose stools, rhinitis, urinary disorders, polyuria, abnormal olfaction, taste disturbance, abnormal ocular control, dry eye syndrome, headache, dizziness, weakness, cough, nausea, fatigue, frailty, lower limb edema, angioedema, pruritus, hypersensitivity, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, elevated blood pressure, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, indigestion, diarrhea, pain, urinary tract infection, erectile dysfunction, back pain, abdominal pain, muscle spasms, bradycardia, eosinophilia, thrombocytopenia, increased uric acid, liver dysfunction, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, angioedema, hypersensitivity, headache, dizziness, constipation, nausea, abdominal pain, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, dysuria, rhinitis, oropharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light, so it should be stored in a container that does not allow light in. It is also important to maintain a temperature between 1 degree Celsius and 30 degrees Celsius when storing the medication. This ensures that the effectiveness is well preserved and can be used safely.
Bright pink oval film-coated tablet
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.